Abstract 4337093: Association between atherogenic index of plasma and long-term prognosis in patients with Cardiovascular–kidney–metabolic syndrome stages 4: a retrospective cohort study involving 7,672 individuals.

Background: The atherogenic index of plasma (AIP) is closely associated with various metabolic disorders, cardiovascular diseases, and chronic kidney disease, and it has also been shown to correlate with cardiovascular risk in patients with Cardiovascular-kindey-metabolic syndrome (CKM) stages 0-3; however, the role of AIP in the prognosis of patients with CKM stage 4 remains to be investigated. Methods: This study used data from the MIMIC database, with outcome events defined as long-term mortality and 365-day mortality. We examined the relationship between the AIP and the occurrence of outcome events in patients with CKM stage 4 using Kaplan-Meier curves, restricted cubic splines (RCS), and Cox proportional hazards models, while ensuring the robustness of our conclusions through subgroup analyses and interaction terms. Results: A total of 7,672 patients were included, of whom 4,466 (58.2%) were male. Multivariable Cox analysis revealed that compared to the lowest quartile, the hazard ratio (HR) for follow-up mortality in the highest quartile was 1.27 (95% CI: 1.11-1.46, P<0.001), and the HR for 365-day mortality was 1.39 (95% CI: 1.17-1.66, P<0.001). The risk of death increased linearly with increasing AIP (P for trend < 0.05). The results from the RCS, subgroup analyses, and interaction terms confirmed the robustness of these conclusions. Conclusions: AIP is an independent risk factor for the long-term prognosis of patients with CKM stage 4, and this index can serve as an effective indicator for risk stratification upon admission and long-term prognosis assessment. Monitoring AIP and implementing early interventions for dyslipidemia may help improve survival rates in patients with CKM stage 4. Keywords: Atherogenic index of plasma, Cardiovascular-kindey-metabolic syndrome, Long-term prognosis, Retrospective cohort study

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4337093
Primary Topic
Cardiovascular Health and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4337093: Association between atherogenic index of plasma and long-term prognosis in patients with Cardiovascular–kidney–metabolic syndrome stages 4: a retrospective cohort study involving 7,672 individuals.

Jia‐Hao Dou, Wei Jin, Chen Guo, Fan-Shun Guo
Circulation
Cardiovascular Health and Risk Factors
article

Abstract 4337093: Association between atherogenic index of plasma and long-term prognosis in patients with Cardiovascular–kidney–metabolic syndrome stages 4: a retrospective cohort study involving 7,672 individuals.

Jia‐Hao Dou, Wei Jin, Chen Guo, Fan-Shun Guo
article en

Abstract

Background: The atherogenic index of plasma (AIP) is closely associated with various metabolic disorders, cardiovascular diseases, and chronic kidney disease, and it has also been shown to correlate with cardiovascular risk in patients with Cardiovascular-kindey-metabolic syndrome (CKM) stages 0-3; however, the role of AIP in the prognosis of patients with CKM stage 4 remains to be investigated. Methods: This study used data from the MIMIC database, with outcome events defined as long-term mortality and 365-day mortality. We examined the relationship between the AIP and the occurrence of outcome events in patients with CKM stage 4 using Kaplan-Meier curves, restricted cubic splines (RCS), and Cox proportional hazards models, while ensuring the robustness of our conclusions through subgroup analyses and interaction terms. Results: A total of 7,672 patients were included, of whom 4,466 (58.2%) were male. Multivariable Cox analysis revealed that compared to the lowest quartile, the hazard ratio (HR) for follow-up mortality in the highest quartile was 1.27 (95% CI: 1.11-1.46, P<0.001), and the HR for 365-day mortality was 1.39 (95% CI: 1.17-1.66, P<0.001). The risk of death increased linearly with increasing AIP (P for trend < 0.05). The results from the RCS, subgroup analyses, and interaction terms confirmed the robustness of these conclusions. Conclusions: AIP is an independent risk factor for the long-term prognosis of patients with CKM stage 4, and this index can serve as an effective indicator for risk stratification upon admission and long-term prognosis assessment. Monitoring AIP and implementing early interventions for dyslipidemia may help improve survival rates in patients with CKM stage 4. Keywords: Atherogenic index of plasma, Cardiovascular-kindey-metabolic syndrome, Long-term prognosis, Retrospective cohort study

CirculationVol. 152(Suppl_3)
Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Openalex Percentile: Top 51%
Cardiovascular Health and Risk Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.